Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant Cytokeratin 5 anticorps (AA 316-590)

Cet anticorps Souris Monoclonal détecte spécifiquement Cytokeratin 5 dans IHC et IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7126613

Aperçu rapide pour Recombinant Cytokeratin 5 anticorps (AA 316-590) (ABIN7126613)

Antigène

Voir toutes Cytokeratin 5 (KRT5) Anticorps
Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 148
  • 85
  • 56
  • 12
  • 10
  • 10
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 104
  • 54
  • 2
Souris

Clonalité

  • 88
  • 72
Monoclonal

Conjugué

  • 72
  • 17
  • 10
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Cytokeratin 5 est non-conjugé

Application

  • 99
  • 73
  • 48
  • 33
  • 30
  • 22
  • 19
  • 14
  • 13
  • 10
  • 9
  • 8
  • 6
  • 5
  • 3
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 16
    • 16
    • 15
    • 12
    • 10
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 316-590

    Specificité

    This Mab recognizes a protein of 58 kDa, which is identified as Cytokeratin 5 (KRT5). This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Antibodies to KRT5 identify basal cells of squamous and glandular epithelia, yoepithelial, and mesothelium.Anti-cytokeratin 5 has been reported useful in the differential diagnosis of metastatic carcinoma in the pleura versus epithelioid mesothelioma. Almost all squamous cell carcinomas, half of transitional carcinomas, and many undifferentiated large cell carcinomas express.Anti-KRT5, along with anti-p63, affords a high sensitivity and specificity for squamous differentiation. Myoepithelial cells of the breast, glandular epithelia, and basal cells of the prostate are labeled with anti-KRT5.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment (around aa 316-590) of human Cytokeratin 5 (KRT5) protein (exact sequence is proprietary)

    Isotype

    IgG2a
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil, esophagus or bladder tissue (IHC).

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

    Autre désignation

    KRT5

    Sujet

    58 kDa Cytokeratin, DDD1, Epidermolysis Bullosa Simplex 2 (EBS2), Keratin 5, Keratin, Type II Cytoskeletal 5, Keratin-5, Type-II Cytoskeletal 5, Type-II keratin Kb5,Cytokeratin 5 (KRT5) (Basal, Myoepithelial & Mesothelial Cell Marker)
    Cellular localisation: Cytoplasmic

    Poids moléculaire

    58kDa

    ID gène

    3852, 433845

    UniProt

    P13647
Vous êtes ici:
Chat with us!